TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Inclusion Criteria:
Exclusion Criteria:
lburch@pedestalhealth.com
ddevane@pedestalhealth.com9842340268
Winston-Salem, North Carolina 27157, United States
Irma.Richardson@advocatehealth.org336-716-7740
Adult patients and patients under the age of majority with a diagnosis of DD by ICD or other relevant healthcare code in the EHR interface.
Adult patients and patients under the age of majority diagnosed and managed for DD invited to participate OR HCPs who treat patients with these conditions. * Informed consent is required for all participants in an Engaged Cohort. * Willing to complete required Engaged Cohort activities.
cotp@musc.edu843-792-3746
rowle@musc.edu843-792-9784
A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Observational Evaluation of Atopic Dermatitis in Pediatric Patients